Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Lakefront Biotherapeutics NV (LKFT) is an innovative biopharmaceutical company focused on addressing significant unmet medical needs in oncology and infectious diseases through its proprietary therapies. With a robust pipeline that integrates advanced biologics and small molecules, the company is committed to enhancing patient outcomes and advancing its clinical programs. Lakefront prioritizes the formation of strategic partnerships to amplify its research capabilities and expand market presence, positioning itself as a future leader in the biotherapeutics space. The company’s dedication to scientific excellence ensures a patient-centric approach in developing transformative healthcare solutions.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$27.99
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Mar 31, 2026 Reported May 6, 2026 | $-0.97 | $0.21 | Beat +121.6% | — | — | $6.5M | — | 1D Pre-0.2% | On-Day+1.5% | 1D Post-3.7% |
Q ended Dec 31, 2025 Reported Feb 23, 2026 | $-0.07 | $12.27 | Beat +17628.6% | — | — | $900.8M | — | 1D Pre-1.2% | On-Day+0.3% | 1D Post+1.4% |
Q ended Sep 30, 2025 Reported Nov 5, 2025 | $-0.28 | |||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| $-0.18 |
| Beat +35.7% |
| — |
| — |
| $71.2M |
| — |
| 1D Pre-1.7% |
| On-Day-1.9% |
| 1D Post+4.4% |